Model Organism Screening in the Diagnosis of Rare Genetic Diseases - Ronald Lemire Lecture
Objectives and Disclosures
Participants will be able to:
- Assess how research findings about the function of disease-causing variants (e.g loss of function versus gain of function) can suggest some future goals for therapy (gene therapy, gene editing, oligonucleotides).
- Interpret the impact of undiagnosed disease research on healthcare and medicine.
- Distinguish how gene discovery projects can help the patients involved from the patients that are diagnosed after the research is published.
Seattle Children’s CME Speaker and Planners disclose they have no relevant financial relationships.
Michael Wangler, MD
Associate Professor, Department of Molecular and Human Genetics, Baylor College of Medicine; Human Genetics Researcher, Texas Children’s Neurofibromatosis Clinic, Medical Geneticist, Texas Children’s
CME Credit
Seattle Children’s is accredited by the Washington State Medical Association CME Accreditation Committee to sponsor continuing medical education for physicians.
Seattle Children’s designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 1 hour of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
Videos are available for only one year after posting.
If you wish to receive Category I CME credit for viewing this Provider Grand Rounds session, please complete the evaluation form. Upon completion of the form you will receive an auto-reply email that will serve as the only confirmation of your CME credit. Please keep the email for your records.
Provider News
The monthly Provider News email provides updates for healthcare professionals about programs and services at Seattle Children’s.
Want to receive Provider News via email? Subscribe now.